Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.025 GBX | +12.04% | +23.47% | +23.47% |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Financials (USD)
Sales 2021 | 7.39 | Sales 2022 | 8.17 | Capitalization | 8.27M |
---|---|---|---|---|---|
Net income 2021 | -2M | Net income 2022 | -2M | EV / Sales 2021 | 4,998,796 x |
Net cash position 2021 | 1.35M | Net Debt 2022 | 2.35M | EV / Sales 2022 | 1,300,570 x |
P/E ratio 2021 |
-11
x | P/E ratio 2022 |
-3.14
x | Employees | 86 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 32.99% |
1 day | +12.04% | ||
1 week | +23.47% | ||
Current month | +31.52% | ||
1 month | +21.00% | ||
3 months | +26.04% | ||
6 months | +0.83% | ||
Current year | +23.47% |
Managers | Title | Age | Since |
---|---|---|---|
Simon Deacon
CEO | Chief Executive Officer | 51 | 19-07-31 |
James Snooks
DFI | Director of Finance/CFO | 53 | 20-08-31 |
Andrew Hempsall
COO | Chief Operating Officer | 55 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Deacon
CEO | Chief Executive Officer | 51 | 19-07-31 |
Andrew Hempsall
COO | Chief Operating Officer | 55 | 20-07-31 |
James Snooks
DFI | Director of Finance/CFO | 53 | 20-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 3.025 | +12.04% | 3 697 245 |
24-05-08 | 2.7 | +10.20% | 1,770,815 |
24-05-07 | 2.45 | 0.00% | 47,665 |
24-05-03 | 2.45 | 0.00% | 0 |
24-05-02 | 2.45 | 0.00% | 202,260 |
Delayed Quote London S.E., May 09, 2024 at 05:01 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.47% | 11.23M | |
-17.06% | 14.96B | |
+17.02% | 11.36B | |
+20.88% | 8.63B | |
+46.43% | 8.57B | |
+7.39% | 8.89B | |
-8.42% | 8.31B | |
-12.78% | 6.89B | |
-15.97% | 6.61B | |
+27.91% | 6.44B |
- Stock Market
- Equities
- LST Stock